Abstract
Background
Risk factors for acute kidney injury (AKI) in pediatric patients after hematopoietic stem cell transplantation (HSCT) remain controversial.
Objectives
This study aimed to identify risk factors for AKI following HSCT in the pediatric population.
Data sources
PubMed, Embase, Web of Science, Cochrane Library, and Scopus databases were searched from inception to February 8, 2023.
Study eligibility criteria
Studies meeting the following criteria were included: (1) The study was a case-control, cohort study, or cross-sectional design, (2) the study was performed among pediatric and young patients aged 21 years or younger undergoing HSCT, (3) the study measured at least one related factor for AKI after pediatric HSCT, (4) the study included a sample of at least ten patients, and (5) original articles published in English in peer-reviewed scientific journals.
Participants and interventions
Children who were undergoing pediatric HSCT.
Study appraisal and synthesis methods
We assessed the quality of the included studies and analyzed them with a random-effect model.
Results
Fifteen studies with a total of 2,093 patients were included. All were cohort studies of high quality. The overall pooled incidence of AKI was 47.4% (95%CI 0.35, 0.60). We found significant associations between post-transplant AKI in pediatric patients and unrelated donor [odds ratio (OR) = 1.74, 95% confidence interval (CI) 1.09–2.79], cord blood stem cell transplantation (OR = 3.14, 95%CI 2.14–4.60), and veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) (OR = 6.02, 95%CI 1.40–25.88). Other controversial factors such as myeloablative conditioning (MAC), acute graft vs. host disease (aGVHD), and the use of calcineurin inhibitors (CNI) were not found to be related to AKI after pediatric HSCT.
Limitations
Results were limited mainly by heterogeneity in the characteristics of patients and transplantation.
Conclusions and implications of key findings
Posttransplant AKI in children is a common complication. Unrelated donors, cord blood stem cell transplantation, and VOD/SOS might be risk factors for AKI after pediatric HSCT. Further large-scale studies are still needed to draw firm conclusions.
Systematic review registration number
CRD42022382361
Graphical abstract
Similar content being viewed by others
References
Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb JT, Basu RK, Bissler J, Felix MB, Brophy P, Bunchman T, Alhasan K, Haffner D, Kim YH, Licht C, McCulloch M, Menon S, Onder AM, Khooblall P et al (2022) Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus. Pediatr Nephrol 37:1179–1203. https://doi.org/10.1007/s00467-022-05448-x
Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL (2006) 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184–189. https://doi.org/10.1038/sj.ki.5000032
Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, Matsell DG (2012) Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59:523–530. https://doi.org/10.1053/j.ajkd.2011.10.048
Sutherland SM, Byrnes JJ, Kothari M, Longhurst CA, Dutta S, Garcia P, Goldstein SL (2015) AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. Clin J Am Soc Nephrol 10:554–561. https://doi.org/10.2215/cjn.01900214
Benoit SW, Dixon BP, Goldstein SL, Bennett MR, Lane A, Lounder DT, Rotz SJ, Gloude NJ, Lake KE, Litts B, Davies SM (2019) A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 54:1453–1461. https://doi.org/10.1038/s41409-018-0428-6
Didsbury MS, Mackie FE, Kennedy SE (2015) A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients. Pediatr Transplant 19:460–470. https://doi.org/10.1111/petr.12483
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z
Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Community Health 67:974–978. https://doi.org/10.1136/jech-2013-203104
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14:135. https://doi.org/10.1186/1471-2288-14-135
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558. https://doi.org/10.1002/sim.1186
Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055. https://doi.org/10.1016/s0895-4356(01)00377-8
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629
Holthe JEK, van Zwet JML, Brand R, van Weel MH, Vossen J, van der Heijden AJ (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 22:559–564. https://doi.org/10.1038/sj.bmt.1701388
Kist-van Holthe JE, Goedvolk CA, Brand R, van Weel MH, Bredius RGM, van Oostayen JA, Vossen J, van der Heijden BJ (2002) Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 17:1032–1037. https://doi.org/10.1007/s00467-002-0989-9
Esiashvili N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH, Paulino AC (2009) Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90:242–246. https://doi.org/10.1016/j.radonc.2008.09.017
Hazar V, Gungor O, Guven AG, Aydin F, Akbas H, Gungor F, Tezcan G, Akman S, Yesilipek A (2009) Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer 53:197–202. https://doi.org/10.1002/pbc.22030
Ileri T, Ertem M, Ozcakar ZB, Ince EU, Biyikli Z, Uysal Z, Ekim M, Yalcinkaya F (2010) Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 14:138–144. https://doi.org/10.1111/j.1399-3046.2009.01182.x
Satwani P, Bavishi S, Jin Z, Jacobson JS, Baker C, Duffy D, Lowe L, Morris E, Cairos MS (2011) Risk factors associated with kidney injury and the impact of kidney injury on overall survival in pediatric recipients following allogeneic stem cell transplant. Biol Blood Marrow Transplant 17:1472–1480. https://doi.org/10.1016/j.bbmt.2011.02.006
Kizilbash SJ, Kashtan CE, Chavers BM, Cao Q, Smith AR (2016) Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22:1264–1270. https://doi.org/10.1016/j.bbmt.2016.03.014
Cordero C, Loboda C, Clerc-Urmès I, Clément L, Pochon C, Chastagner P (2017) Unexpected acute renal injury after high-dose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 64(12):e26669. https://doi.org/10.1002/pbc.26669
Barnoud D, Pinçon C, Bruno B, Béné J, Gautier S, Lahoche A, Petitpain N, Vasseur M, Barthélémy C, Décaudin B, Simon N, Odou P (2018) Acute kidney injury after high dose etoposide phosphate: a retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation. Pediatr Blood Cancer 65:e27038. https://doi.org/10.1002/pbc.27038
Benoit SW, Goldstein SL, Dahale DS, Haslam DB, Nelson A, Truono K, Davies SM (2019) Reduction in nephrotoxic antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant 25:1654–1658. https://doi.org/10.1016/j.bbmt.2019.04.022
Daraskevicius J, Azukaitis K, Dziugeviciute-Tupko J, Peciulyte M, Planciunaite R, Vaitkeviciene G, Rascon J, Jankauskiene A (2020) Phenotypes and baseline risk factors of acute kidney injury in children after allogeneic hematopoietic stem cell transplantation. Front Pediatr 8:499. https://doi.org/10.3389/fped.2020.00499
Hirano D, Kakegawa D, Miwa S, Umeda C, Takemasa Y, Tokunaga A, Kawakami Y, Ito A (2020) Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study. BMC Nephrol 21:373. https://doi.org/10.1186/s12882-020-02045-8
Augystynowicz M, Kalwak K, Zwolinska D, Musial K (2021) The incidence of acute kidney injury in children undergoing allogenic hematopoietic stem cell transplantation: a pilot study. Adv Clin Exp Med 30:87–92. https://doi.org/10.17219/acem/130355
Gurbanov A, Gulhan B, Kuskonmaz B, Okur FV, Ozaltin F, Duzova A, Cetinkaya DU, Topaloglu R (2022) Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation. Pediatr Nephrol 38:461–469. https://doi.org/10.1007/s00467-022-05599-x
Bauer A, Carlin K, Schwartz SM, Srikanthan M, Thakar M, Burroughs LM, Smith J, Hingorani S, Menon S (2022) Risk factors for severe acute kidney injury after pediatric hematopoietic cell transplantation. Pediatr Nephrol 38:1365–1372. https://doi.org/10.1007/s00467-022-05731-x
Kataria Y (2017) Epidemiology of acute kidney injury in critically ill children and young adults. Ann Clin Biochem 54:416. https://doi.org/10.1177/0004563217693559
Keddis M, Leung N, Herrmann S, El-Zoghby Z, Sethi S (2012) Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia. Am J Kidney Dis 59:886–890. https://doi.org/10.1053/j.ajkd.2011.10.056
Gatza E, Reddy P, Choi SW (2020) Prevention and treatment of acute graft-versus-host disease in children, adolescents, and young adults. Biol Blood Marrow Transplant 26:e101–e112. https://doi.org/10.1016/j.bbmt.2020.01.004
Arslan S, Al Malki MM (2022) New strategies for mismatched unrelated donor (MMUD) hematopoietic cell transplant (HCT). Hematol Am Soc Hematol Educ Program 2022:74–82. https://doi.org/10.1182/hematology.2022000398
Lucchini G, Perales MA, Veys P (2015) Immune reconstitution after cord blood transplantation: peculiarities, clinical implications and management strategies. Cytotherapy 17:711–722. https://doi.org/10.1016/j.jcyt.2015.03.614
Keating AK, Langenhorst J, Wagner JE, Page KM, Veys P, Wynn RF, Stefanski H, Elfeky R, Giller R, Mitchell R, Milano F, O'Brien TA, Dahlberg A, Delaney C, Kurtzberg J, Verneris MR, Boelens JJ (2019) The influence of stem cell source on transplant outcomes for pediatric patients with acute myeloid leukemia. Blood Adv 3:1118–1128. https://doi.org/10.1182/bloodadvances.2018025908
Wang J, Zhan P, Ouyang J, Chen B, Zhou R, Yang Y (2010) Unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients: a meta-analysis. Leuk Res 34:1018–1022. https://doi.org/10.1016/j.leukres.2009.11.020
Timofeeva OA, Philogene MC, Zhang QJ (2022) Current donor selection strategies for allogeneic hematopoietic cell transplantation. Hum Immunol 83:674–686. https://doi.org/10.1016/j.humimm.2022.08.007
Parikh CR, Schrier RW, Storer B, Diaconescu R, Sorror ML, Maris MB, Maloney DG, McSweeney P, Storb R, Sandmaier BM (2005) Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation. Am J Kidney Dis 45:502–509. https://doi.org/10.1053/j.ajkd.2004.11.013
Yu ZP, Ding JH, Chen BA, Liu BC, Liu H, Li YF, Ding BH, Qian J (2010) Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation. Chin J Cancer 29:946–951. https://doi.org/10.5732/cjc.010.10293
Frisk P, Bratteby LE, Carlson K, Lönnerholm G (2002) Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29:129–136. https://doi.org/10.1038/sj.bmt.1703312
Tarbell NJ, Guinan EC, Chin L, Mauch P, Weinstein HJ (1990) Renal insufficiency after total body irradiation for pediatric bone marrow transplantation. Radiother Oncol 18(Suppl 1):139–142. https://doi.org/10.1016/0167-8140(90)90195-3
Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB (2007) Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39:223–229. https://doi.org/10.1038/sj.bmt.1705573
Leblond V, Sutton L, Jacquiaud C, Item C, Sadoun R, Jaudon MC, Raymond F, Jacobs C, Deray G (1995) Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 6:1661–1665. https://doi.org/10.1681/asn.V661661
Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz JM, Chapuis B (1996) Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 14:579–585. https://doi.org/10.1200/jco.1996.14.2.579
Delgado J, Cooper N, Thomson K, Duarte R, Jarmulowicz M, Cassoni A, Kortaridis P, Peggs K, Mackinnon S (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 12:75–83. https://doi.org/10.1016/j.bbmt.2005.08.036
Kal HB, van Kempen-Harteveld ML (2006) Renal dysfunction after total body irradiation: dose-effect relationship. Int J Radiat Oncol Biol Phys 65:1228–1232. https://doi.org/10.1016/j.ijrobp.2006.02.021
Inose R, Takahashi K, Takahashi M, Sugimoto T, Nanno S, Hino M, Nagayama K (2022) Long-term use of foscarnet is associated with an increased incidence of acute kidney injury in hematopoietic stem cell transplant patients: a retrospective observational study. Transpl Infect Dis 24:e13804. https://doi.org/10.1111/tid.13804
Tashiro M, Obata Y, Takazono T, Ota Y, Wakamura T, Shiozawa Y, Tsuyuki A, Miyazaki T, Nishino T, Izumikawa K (2022) Association between fluid infusions and the recovery from acute kidney injury in patients administered liposomal amphotericin B: a nationwide observational study. Ren Fail 44:282–292. https://doi.org/10.1080/0886022x.2022.2036618
Ma RW, Kwan JM, Ma DD, Fay KC (2010) Acute life-threatening cardiovascular toxicity with umbilical cord blood infusion: the role of dextran. Am J Hematol 85:722–724. https://doi.org/10.1002/ajh.21797
Abramson MH, Gutgarts V, Zheng J, Maloy MA, Ruiz JD, Scordo M, Jaimes EA, Sathick IJ (2021) Acute kidney injury in the modern era of allogeneic hematopoietic stem cell transplantation. Clin J Am Soc Nephrol 16:1318–1327. https://doi.org/10.2215/cjn.19801220
Radermacher J, Meiners M, Bramlage C, Kliem V, Behrend M, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R (1998) Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 11:3–10. https://doi.org/10.1007/s001470050094
McDaniel BL, Bentley ML (2015) The role of medications and their management in acute kidney injury. Integr Pharm Res Pract 4:21–29. https://doi.org/10.2147/iprp.S52930
Patzer L (2008) Nephrotoxicity as a cause of acute kidney injury in children. Pediatr Nephrol 23:2159–2173. https://doi.org/10.1007/s00467-007-0721-x
Raina R, Abusin GA, Vijayaraghavan P, Auletta JJ, Cabral L, Hashem H, Vogt BA, Cooke KR, Abu-Arja RF (2018) The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation. Pediatr Transplant 22. https://doi.org/10.1111/petr.13139
Roeker LE, Kim HT, Glotzbecker B, Nageshwar P, Nikiforow S, Koreth J, Armand P, Cutler C, Alyea EP, Antin JH, Richardson PG, Soiffer RJ, Ho VT (2019) Early clinical predictors of hepatic veno-occlusive disease/sinusoidal obstruction syndrome after myeloablative stem cell transplantation. Biol Blood Marrow Transplant 25:137–144. https://doi.org/10.1016/j.bbmt.2018.07.039
DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22:27–42. https://doi.org/10.1055/s-2002-23204
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 2.95 MB)
Graphical Abstract
(PPTX 892 KB)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Huang, B., Shan, J., Yi, L. et al. Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Pediatr Nephrol 39, 397–408 (2024). https://doi.org/10.1007/s00467-023-05964-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-05964-4